Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × vosaroxin × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

OTHER 5 INDUSTRY 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

fludarabine 4 Cyclophosphamide 4 Cytarabine 3 Azacitidine 3 venetoclax 2 pegylated granulocyte colony-stimulating factor 2 Etoposide 2 Dasatinib 2 vosaroxin 1 treosulfan 1 peginterferon alfa-2a 1 nilotinib 1 liposomal amphotericin B 1 fludarabine phosphate 1 defactinib 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 cc-486 1 bisantrene 1 aldesleukin 1 Zinc Sulfate 1 Zinc 1 Vitamin D 1 Urination 1 Tranexamic Acid 1 Thiotepa 1 Simvastatin 1 S Phase 1 Ploidies 1 Platelet Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02416388 2024-08-07

BIG-1

University Hospital, Angers

Phase 2/3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡